Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Zonisamide (zonegran) manufacturing plant cost?

See the DrugPatentWatch profile for Zonisamide

A quick‑look snapshot of what it takes to build a Zonisamide (Zonegran™) manufacturing plant

Item Typical cost range (US$) Notes
Land & site prep 0.5 – 3 M Depends on local real‑estate markets, zoning, and environmental compliance.
Building & clean‑room construction 3 – 10 M For a 3–5 k m² facility with ISO‑7 clean‑room space and ancillary areas.
Process‑development & scale‑up 1 – 5 M Includes pilot‑scale reaction vessels, chromatography, and analytical development.
Primary synthesis equipment 1 – 4 M Batch reactors (1–5 t capacity), mixers, pumps, heat exchangers.
Purification & isolation 0.5 – 3 M Distillation columns, crystallizers, filtration units, lyophilizers.
Quality‑control (QC) labs 0.5 – 2 M HPLC, GC, MS, assay, and stability testing.
Packaging & labeling 0.5 – 2 M Tablets, blister packs, labeling, packaging automation.
Utilities & HVAC 1 – 3 M Water‑purification, compressed‑air, HVAC for clean‑room.
Information‑technology & automation 0.5 – 1.5 M MES, LIMS, SCADA, and ERP integration.
Regulatory & compliance 0.5 – 2 M GMP certification, inspections, documentation.
Contingency (10‑20 %) 1 – 5 M For scope changes, delays, and price inflation.

Grand total (pilot‑scale, 3 k m² facility): ~US$ 15 – 30 million


Why the range is so wide

Driver What matters
Facility size 5 k m² vs. 20 k m² changes equipment count and clean‑room volume by 3–4×.
Scale of production Batch‑size (1 t vs. 10 t) impacts reactor size, auxiliary equipment, and utilities.
Technology choice Continuous flow vs. batch synthesis: continuous can cut CAPEX but needs more advanced control systems.
Location U.S. or EU plants are roughly 1.5–2× more expensive than plants in emerging‑market countries due to labor, real estate, and regulatory costs.
Regulatory regime FDA GMP vs. EMA GMP: similar, but FDA inspections sometimes require additional audit support.
Supply‑chain and vendor pricing Equipment vendors vary widely; local suppliers can reduce shipping and import duties.
Environmental and safety requirements Hazardous‑chemical handling, waste treatment, and VOC controls add to both CAPEX and OPEX.

Bottom‑line take‑away

  • Pilot‑scale (enough to produce a few hundred kilograms of Zonisamide per batch) typically costs US$ 15–30 million in CAPEX.
  • Commercial‑scale (tens of tons per batch, continuous plant) can run US$ 60–200 million or more, depending on the scale and automation level.
  • Operational expenses (OPEX)—raw materials, utilities, QC, labor, maintenance—will add $2–5 M per year for a mid‑size commercial plant.

If your goal is to start production without the massive CAPEX of building a new plant, a common pathway is to partner with a Contract Manufacturing Organization (CMO). CMOs can provide Zonisamide manufacturing under GMP with a lower upfront investment, but you’ll pay a per‑gram or per‑batch fee that typically ranges from $0.02–$0.10 per mg (depending on scale and specifications).


Where to find more concrete numbers

Source What you get
Industry reports (e.g., IQVIA, Grand View Research) Market‑wide CAPEX/OPEX benchmarks for drug manufacturing.
Regulatory guidance (FDA, EMA, ICH Q7) Requirements that drive facility design and equipment needs.
CMO service listings Quotes that reflect real‑world pricing for Zonisamide production.
Academic literature Case studies on the synthesis of Zonisamide (e.g., reaction‑scale, purification steps).

Tip: For a tailored cost estimate, work with a process‑engineering consulting firm that can model your specific Zonisamide synthesis route, batch size, and regulatory pathway.


Bottom line
Setting up a Zonisamide manufacturing plant is a capital‑intensive endeavor, typically running from a few million dollars for a small pilot plant to well over a hundred million for a full‑scale commercial facility. The actual cost hinges on your scale, location, technology, and the regulatory environment. If the upfront cost is prohibitive, consider a CMO partnership—many contract manufacturers already have the GMP infrastructure to produce Zonisamide and can deliver high‑quality product at a predictable cost.



Other Questions About Zonisamide :

Zonisamide oral suspension? Generic for zonisamide? Zonisamide impurity manufacturers? Cost of zonisamide? Zonisamide? Zonisamide coupon? Zonisamide coupons?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
40
Visibility
40
Mentioned
Ranking
#1
Sentiment
41
Recommendation Status
mentioned only
Brand Perception
Best Known For

Zonisamide’s patent protection is already expired


Core Claims
  • A zonisamide (Zonegran) manufacturing plant cost depends on physical, regulatory, and market factors.
  • A mid-scale plant for zonisamide might fall between $30 million and $50 million depending on process route and scale.
  • Zonisamide’s synthesis steps and stricter purity requirements push cost upward versus a generic acetaminophen plant.
  • Zonisamide’s patent protection is already expired, but exclusivity on certain process patents or formulation advantages may allow a new entrant to charge a premium.
Differentiators
  • Described as a small molecule synthesized via a multi-step process.
  • Synthesis steps and stricter purity requirements push costs upward compared to acetaminophen.
  • Potential premium tied to exclusivity on certain process patents or formulation advantages.

Pricing Perception: Mid Range